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Background/aim: Approximately 40 million individuals worldwide have been infected with SARS-CoV-2, the virus responsible for
the novel coronavirus disease-2019 (COVID-19). Despite the current literature about the cardiac effects of COVID-19 in children,
more information is required. We aimed to determine both cardiovascular and arrhythmia assessment via electrocardiographic and
echocardiographic parameters.
Materials and methods: We evaluated seventy children who were hospitalized with COVID-19 infections and seventy children as
normal control group through laboratory findings, electrocardiography (ECG), and transthoracic echocardiography (TTE).
Results: We observed significantly increased levels of Tp-Te, Tp-Te/QT, and Tp-Te/QTc compared with the control group. Twenty-five
of 70 (35.7%) patients had fragmented QRS (fQRS) without increased troponin levels. On the other hand, none of the patients had
pathologic corrected QT(QTc) prolongation during the illness or its treatment. On TTE, 20 patients had mild mitral insufficiency,
among whom only five had systolic dysfunction (ejection fraction < 55%). There was no significant difference between the patient and
control groups, except for isovolumic relaxation time (IVRT) in terms of mean systolic and diastolic function parameters. IVRT of
COVID patients was significantly lower than that of control group.
Conclusion: Despite all the adult studies, the effects of COVID‐19 on myocardial function are not well established in children. The
thought that children are less affected by the illness may be a misconception.
Key words: Children, COVID-19, electrocardiography, risk

1. Introduction
The coronavirus disease (COVID-19), which started in
Wuhan, China, in December 2019, and was declared a
worldwide pandemic by the World Health Organization
(WHO) on March 11th, 2020, is a novel infectious disease
that causes respiratory illness and death [1]. Millions of
individuals worldwide have been infected by COVID-19,
with approximately 40 million infections worldwide at
the time of writing1. Most of the studies in the literature
about the cardiac manifestations of COVID-19 including
myocarditis and arrhythmias, electrocardiographic
changes including ST segment-T wave changes, and
laboratory abnormalities such as elevated high-sensitivity
troponin T and N-terminal pro-brain-type natriuretic
peptide (NT-pro BNP), have been in adults [2–4]. Such
studies were also reported with fragmented QRS (fQRS).

fQRS as a manifestation of local conduction abnormalities
in the ventricular myocardium and scar tissue has been
established several times in the literature [5].
COVID-19 can lead to cardiac injury via the following
possible mechanisms [6]; 1) increased cytokines and
immune-inflammatory response cause indirect injury, 2)
direct invasion of cardiomyocytes with virus, 3) effects due
to lung failure, and 4) hypoxia leading to oxidative stress
and injury to cardiomyocytes. The pathophysiology is still
unclear; why are these abnormalities related to increased
mortality and morbidity during illness?
In the first stages of the pandemic, COVID-19 was
observed to cause lesser effects in children in clinical
evaluation, but later, and with mutations of the virus,
different and more serious signs and symptoms of the
illness were seen in children by physicians [7].

World Health Organization. Coronavirus disease 2019 (COVID‐19): situation report– 70.2020. https://www.who.int/docs/defaultsource/coronavirus/
situationreports/20200330‐sitrep‐70‐covid‐19.pdfsfvrsn=7e0fe3f8-4. [Accessed 30 March 2020].
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In this study, we evaluated the cardiac functions of
COVID-19 infected children who were hospitalized
in a tertiary hospital using electrocardiography,
echocardiography, and laboratory findings.
2. Materials and methods
We presented a cross-sectional analysis of 70 children
hospitalized with COVID-19 infections, who had
respiratory distress, intractable fever, angina, and
gastrointestinal symptoms in the first months of the
disease (March 15th-June 30th 2020).
The study was approved by the local ethics committee
of University (Date: 24.07.2020-09.2020.717), and the
Turkish Ministry of Health (2020-06-08/T19-55-10).
The patients were appraised through laboratory
findings, electrocardiography (ECG), and transthoracic
echocardiography (TTE). The patients were initially
diagnosed according to clinical manifestations and
exposure history. All patients were evaluated using
laboratory markers such as white blood cell (WBC) count,
C-reactive protein, Pro BNP, COVID-19, polymerase
chain reaction (PCR), troponin T levels, coagulation
parameters, chest X-ray, ECG, and TTE. Chest X-Rays
were evaluated by two radiologist, who defined the results
as normal, lober pneumonia, and ground-glass opacities
were observed, which are the most common findings of
the chest X-Rays of this disease [8].
On the ECG, the risk of arrhythmia was observed
by the evaluation of depolarization and repolarization
parameters (such as Tp-Te interval, Tp-Te/QTc, Tp-Te/QT
ratio) and cardiac ventricle systolic and diastolic functions
employing ejection fraction, fractional shortening, and
Doppler parameters. In the acute phase of the illness, the
ECG and TTE parameters were correlated with the normal
age and sex-matched healthy children as control group (n
= 70).
2.1. Electrocardiographic measurements
A 12-lead electrocardiogram with standard chest and limb
leads was used to evaluate the Tp-Te interval, QTc interval,
QTd interval, and presence of fQRS. The 12-lead ECG
was recorded at a paper speed of 50 mm/s in the supine
position. To decrease measurement errors, all ECGs
were scanned and transferred to a personal computer
and then used for 400% magnification with the Adobe
Photoshop software. QTd was calculated as the difference
between the longest and the shortest QT intervals. ECG
measurements of QTc and Tp-Te intervals were performed
by two cardiologists who were blinded to the patient data.
Subjects with U waves on their ECGs were excluded from
the study. An average value of 3 readings were calculated
for each lead. The QT interval was measured from the
beginning of the QRS complex to the end of the T wave
and corrected for heart rate using the Bazett formula: cQT
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= QTÖ (RR interval). The Tp-Te interval was defined as
the interval from the peak of the T wave to the end of
the T wave. Measurements of the Tp-Te interval were
performed from the precordial leads. The Tp-Te/QT ratio
was calculated from these measurements [9] (Figure 1).
Fragmentation of QRS was defined as the presence of
various RSR’ patterns with different morphologies of QRS
complexes. Various RSR’ patterns included additional R
wave (R’), notching of the R wave or the S wave, or the
presence of >1 R’ (fragmentation) without a typical bundle
branch block in two contiguous leads corresponding to a
major lead set for major coronary artery territory [10]. Any
QRS morphology with a QRS duration >120 ms, including
bundle branch block or intraventricular conduction delay,
was excluded.
2.2. Echocardiographic measurements
All patients underwent an echocardiographic examination
using a Philips IE33-model echocardiography device
(Phillips Medical Systems Andover, MD, USA) equipped
with 5-MHz sector transducers. Two-dimensional
echocardiographic images were obtained using apical
four-chamber (4C) and (2C) views, and a parasternal
long axis (LAX) view. Coronary artery involvement was
also examined [11]. Echocardiography was also evaluated
by two pediatric cardiologist (B.S.C;S.A). There was
agreement between intraobserver and interobserver
variability.
Left ventricular functions:
Left ventricular dimensions, interventricular septal
diameter (IVSD), LVPWD (left ventricular posterior
wall diameter), and LVED (left ventricle end diastole)

Figure 1. To calculate Tp-Te, Tp-Te/QT-, and QTc interval.
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and LVEDS (left ventricle end systole) dimensions were
measured, and left ventricular ejection and shortening
fractions (LVEF-SF) were calculated using the Teichholtz
formula [12]. Left ventricular diastolic functions were
studied using pulse wave echocardiography with mitral
inflow Doppler velocities; early (E wave) and late (A
wave) velocities, deceleration time, and IVRT were
measured. Isovolumic relaxation time (IVRT) was
measured with PW Doppler, which the transducer is
angulated into the apical 5-chamber or long-axis view
and the sample volume placed within the left ventricle
outflow tract (LVOT), but in proximity to the anterior
mitral valve (MV) leaflet to record both inflow and
outflow signals. Three cardiac cycles should be averaged
when measuring transmitral velocities and IVRT.
3. Statistics
Statistical analysis was performed using the SPSS
Statistics for Windows v.20 software package (SPSS, Inc.,
Chicago, IL, USA). The independent-sample t-test or
Mann–Whitney U test was used to compare continuous
variables. For categorical variables, the Chi-square test was
used. Correlations were evaluated using univariate and
multivariate linear regression analysis. A p-value of <0.05
was accepted as statistical significance. Inter and intra
observer agreement was assessed as 95, 96% respectively.
4. Results
Demographic variables are given in Table 1. The patients
had moderate-severe disease, as previously described in
various studies [13]. Seventy patients were evaluated (girls

Table 1. Demographic characteristics of the patient and control
groups.
Patients
(n = 70)

Controls
(n = 70)

p

Mean age (years)

8.3 ± 6.8

8.32 ± 6.6

0.20

Sex

female 47.1%
male 52.9%

female 50%
male 50%

0.84

Weight (kg)

22.5 ± 5.6

23 ± 6.1

0.77

Height (cm)

126 ± 4.2

125 ± 5.4

0.70

BMI (kg/m2)

15.8 ± 1.1

15.6 ± 1.2

0.69

Overseas contact

none

Exposure to virus

65%

COVID-19 PCR

Positive 81.4%
Negative 18.6%

Covid: coronovirus disease, PCR: polymerase chain reaction,
BMI: Body mass index.

47.1%, boys 52.9%). The mean age of the patients was 8.3 ±
6.8 (minimum 1 month, maximum 18 years). None of the
patients had an anamnesis of overseas contact, 65% had
exposure to a patient 5–15 days before disease onset. The
COVID-19 PCR test was negative in 18.6% of patients and
positive in 81.4%.
Patients whose tests were negative were considered
highly possible to have COVID-19 infection because of
the clinical stature, laboratory markers, and the anamnesis
of exposure to the virus. All these patients had direct
exposure to the virus.
Of the patients admitted to hospital, 52.9% had a fever
(body temperature range, 36.1–38.5 °C); 60% had a cough,
70% patients had symptoms of upper airway disease (nasal
congestion and rhinorrhea), 30% had dyspnea, 14.3% had
a headache, 8.8% had gastrointestinal system symptoms,
4.3% had angina, and 1.4% had anosmia. Some patients
had two or three symptoms together (Figure 2).
The hematologic, serologic, and biochemical
parameters are presented in Table 2. Increased levels of
CRP and procalcitonin were detected. Troponin T, CK and
CK-MB, and Pro BNP levels are shown in Table 3.
Standard signs of the disease in thorax computed
tomography (CT) were seen in 37.1% of the patients. Chest
X-ray results were grouped by two different radiologists as
normal (32.9%), lobar pneumonia (44.3%), and groundglass opacities (22.8%).
All patients were clinically evaluated using a standard
cardiac examination, regardless of the disease severity. The
heart rate was 111 ± 20.3/min (min: 79, max: 170/min).
The mean systolic blood pressure was 106.53 ± 15.77 mm
Hg, and the mean diastolic blood pressure was 68.63 ± 9.9
mm Hg. Oxygen saturation was 82–100 (mean: 96.70 ±
3.05) mm Hg.

Figure 2. Symptom distributions of the children with COVID-19.
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Table 2. Hematologic, serologic, and biochemical parameters of
the patients.

Table 4. ECG parameters of the patient and control groups.

CRP (mg/dL)

31.64 ± 47.81

ECG parameters

Patients
(n = 70)

Controls
(n = 70)

p

Procalcitonin (mg/L)

0.63 ± 1.29

Hb (g/dL)

11.84 ± 2.19

PR (msn)

100.51 ± 17.47

66.28 ± 7.6

0.05

Hct (%)

34 ± 6.25

QRS (msn)

67.85 ± 11.65

56.10 ± 4.98

0.01

WBC (/mm3)

7176 ± 2078

QTc (msn)

422 ± 51.3

389.42 ± 14.92 0.01

Neu (%)

51.2 ± 19

QTd (msn)

96.98 ± 33.95

83.42 ± 7.85

0.02

Plt (/mm3)

247.00 ± 133.00

QTdc (msn)

80.81 ± 7.9

77.15 ± 5.6

0.22

BUN (mg/dL)

9.8 ± 5.7

Tp-Te (msn)

96.85 ± 72

67.10 ± 10.51

0.01

Cr (mg/dL)

0.56 ± 0.38

Tp-Te/QT

0.22 ± 0.008

0.18 ± 0.02

0.01

AST(IU/L)

38 ± 32

Tp-Te/QTc

0.23 ± 0.01

0.16 ± 0.01

0.01

ALT(IU/L)

22.83 ± 21

CRP: C-Reactive protein, Hb: Hemoglobin, Hct: Hematocrite,
Wbc: white blood cell, Neu: neutrofile, Plt: platelet, BUN: blood
urea nitrogen, Cr: creatine, AST: aspartate aminotransferase,
ALT: alanine aminotransferase.

Table 3. Cardiac markers of the patients.

Table 5. Transtorasic echocardiographic parameters of the
patients and control group.
Parameters

Patients
(n = 70)

Controls
(n = 70)

p

MV E (m/sec)

0.73 ± 0.05

0.78 ± 0.07

0.10

MV A (m/sec)

0.69 ± 0.08

0.64 ± 0.02

0.11

IVRT (msn)

58.1 ± 6.55

77.8 ± 7.35

<0.05

CK (U/L)

212.19 ± 57.9

DT (msn)

94.4 ± 18.2

93.02 ± 4.5

0.77

CK-MB (pg/L)

2.18 ± 1.14

IVSD (cm)

0.57 ± 0.07

0.60 ± 0.04

0.75

Troponin-T (ng/L)

17 ± 4.8

LVEDD (mm)

36.47 ± 6.22

36 ± 4.42

0.83

NT-Pro BNP (ng/L)

300

LVESD (mm)

28.29 ± 3.44

27.66 ± 3.22

0.69

LVPWD (cm)

0.70 ± 0.05

0.69 ± 0.04

0.89

FS (%)

29 ± 2.8

32 ± 2.4

0.92

EF(%)

61.2 ± 6.9

65 ± 3.8

0.78

CK: Creatine kinase, CK-MB: Creatine kinase muscle brain NT
Pro BNP: N terminal pro Brain natriuretic peptide.

On the ECG, we evaluated depolarization and
repolarization parameters using QRS, QTd, QTc, TpTe intervals, Tp-Te/QTc, Tp-Te/QTd, fragmented QRS
(fQRS), and pathologic ST-T changes. ECG parameters
were presented in Table 4. Around 47.1% of the patients
had fQRS. None of the patients had either arrhythmia or
pathologic ST-T changes.
We evaluated cardiac functions using systolic and
diastolic functions and coronary artery involvement
with transthoracic echocardiography. These studies were
performed by two echocardiographers using pulse-wave
Doppler and M-mode echocardiography only due to the
risk of infection. Five (7.1%) patients had pericardial
effusion, and 20 (28.5%) patients had mild mitral
insufficiency. Among these, only 5 had systolic dysfunction,
with ejection fraction < 55%. The echocardiographic
parameters of all patients are shown in Table 5.
Three patients were diagnosed as having pediatric
inflammatory multisystem syndrome (PIMS). These
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E: early diastolic mitral inflow velocity, A: late diastolic mitral
inflow velocity, IVRT: isovolumetric relaxation time, IVSD:
interventricular septum diameter, LVPWD: left ventricle
posterior wall diameter, LVESD: left ventricle end-systolic
diameter, LVEDD: left ventricle end-diastolic diameter, FS:
fractional shortening, EF: ejection fraction.

patients had coronary artery involvement with Z scores
>2.5 (Table 6).
Table 7 demonstrates the regression analyses of the
significant values, such as Tp-Te, Tp-Te/Qt, Tp-Te/Qtc,
and IVRT, by means of troponin levels. In this table, TpTe/Qt is found to be a significant predictor of mortality
and morbidity (p: 0 .031, OR: 1.01, 95% CI: 1.22–4.23)
Table 8 shows the univariate analyses of mortality and
morbidity risk of these parameters by means of Covid-19
PCR positivity. Here, Tp-Te is an important predictor of
mortality and morbidity (p: 0.02, OR: 0.99, 95% CI: 0.78–
1.04).
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Table 6. Parameters of patients with paediatric multisystem ınflammatory syndrome.
Patient

Coronary involvement

Tr-T
(ng/L)

NT-pro BNP
(ng/L)

Tp-Te
(msn)

Tp-Te/QT

Tp-Te/QTc

No. 1

LCA fusiform aneurysm

352

600

102

0.22

0.23

No. 2

LAD fusiform aneurysm

162

450

98

0.24

0.22

No. 3

LCA diffuse ectasia

66

400

92

0.22

0.23

LCA: Left coronary artery, LAD: Left anterior descending, NT-pro BNP: n terminal pro brain natriuretic peptide.
Table 7. Regression analysis of the significant values.

Troponin
levels

B

S.E

Tp-Te

0.060

0.061

0.94

0.33

Tp-Te/Qt

0.68

3.16

4.63

Tp-Te/Qtc

–5,18

26.10

IVRT

–0.023

0.05

Wald

p

Exp (B)

95% Confidence
interval for Exp(B)
Lower bound

Upper bound

1.06

0.94

1.19

0.031

1.01

1.22

4.23

0.039

0.84

0.006

3.46

9.75

0.20

0.65

0.97

0.88

1.07

Dependent value: Troponin levels.
Table 8. Univariate logistic regression prediction of mortality
and morbidity.
Variable

c2

p

Odd ratio

95% CI

Age

34.07

0.51

0.99

0.62–0.93

Sex male

0.15

0.93

0.09

0,181–0.196

Tp-Te

40.06

0.02

0.99

0.78–1.04

Tp-Te/Qt

5.54

0.93

2.45

–10.13–12.21

Tp-Te/Qtc

6.49

0.16

3.7

–3.95–6.98

IVRT

3.52

0.85

0.02

–0.016–0.013

Dependent variable: Covid PCR positivity.
CI: Confidence interval,

Patients were treated according to Turkish Ministery of
Health treatment protocol and nonspesific antimicrobial
treatment (Table 9) (Figure 3) [14].
5. Discussion
Most studies suggest that the clinical manifestations of
children are less severe than in adults2. Pediatric patients
respond to SARS-CoV-2 exposure differently. Neonates,

children, and adolescents aged <18 years with COVID-19
are less likely to have any symptoms. Questions remain,
however. Despite the less severe illness, are there any clues
of ECG or TTE parameters during the illness, and are
children safe from the virus as is thought?
In patients, hypotension, arrhythmias, and sudden
cardiac death (SCD) were described as possible SARS‐
CoV manifestations [14]. In a cohort of 121 patients, Yu
et al. demonstrated that sinus tachycardia was the most
common cardiovascular finding with an overall incidence
of 72%. The mean duration of persistent tachycardia was
12.7 days with a mean heart rate of 117 (range, 102–150)
beats/min, and the tachycardia remained persistent
in nearly 40% of patients within 30 days after hospital
discharge. The incidence of tachycardia during the
third week of hospitalization, when most patients were
afebrile, could be related to drug treatment or increased
sympathetic tonus [15].
In our study, we found that the mean heart rate was 120
(range, 105–164) beats/min at the beginning of the illness,
and 112 beats/min after 1 week of treatment when the
patients were afebrile. The mean heart rate after 1 month
was 94 beats/min, which was still slightly increased.
This can be a result of increased sympathetic tonus due
to hypoxia and fever, even in children. Ece et al. also

The Republic of Turkey Ministery of Health COVID-19 Study of Scientific Board. https://hsgm.saglik.gov.tr/depo/birimler/goc_saglıgı/covid19/rehber/
COVID-19_rehberi20200414_eng_v4_002_14.05.2020.pdf.Published2020. [Accessed 14th April 2020].
2
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Table 9. Doses and administration methods of drugs to be used in childhood treatment.
Drug name

Daily dose and administration method on child patients

Duration of
therapy (day)

First day 6.5 mg/kg/dose, 2 times a day hydroxychloroquine sulphate; maximum
dose on first day: 400 mg/dose; continuing on days 2–5 at 3.25 mg/kg/dose,
2 times a day hydroxychloroquine sulphate: maximum dose 200 mg/dose

5 days

First preference
Hydroxychloroquine,
200 mg tablet

Alternative treatment or in case of progress
Lopinavir

250

Babies between 14 days - 6 months old:

mg/ritonavir

50 mg

Lopinavir component 16 mg/kg PO BID

tablet

10–14 days

Children between 6 months - 18 years: 15–25 kg: 200–50 mg PO BID
26–35 kg: 300–75 mg PO BID
>35 kg: 400–100 mg PO BID

Or in adolescents older than 15 years
Favipiravir
200 mg tablet

2 × 1600 mg loading,
2 × 600 mg maintenance

5 days

Additional suggestions to antiviral treatment in confirmed COVID-19 patients who have been put into intensive care unit yet have
organ dysfunction despite supportive therapy; please refer to the intensive care treatment in the guidelines for patients developing
MAS or hemophagocytic syndrome.
AZN: Azitromycin, HCQ: Hydroxychloroquine.

Figure 3. Treatment modalities of our patients.

demostrated significantly elevated heart rate in COVID-19
patients on their recent report [16].
Arrhythmia has been reported as a significant
issue in adult patients [17]. They may be secondary to
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myocardial injury, direct effects of cytokines on sodium
and potassium channels [18], metabolic disturbance [19],
hypoxia [20], and genetic dysrhythmias, which may be
revealed by acute illness or significant stressors, such as
Brugada syndrome [20] and long QT syndromes [21]. We
observed no significant arrhythmias among our patients,
but arrhythmias can be a great concern if they develop
because they can cause serious complications.
In the current study, 47.1% of patients had fQRS. fQRS
can be defined as the presence of additional R’ waves or a
notch in the nadir of the R or S wave (fragmentation) in
two contiguous leads in a routine 12-lead ECG [23]. It is
an important predictor of mortality and arrhythmic events
in many cardiac diseases such as myocardial infarction,
myocarditis, cardiomyopathies, valvular heart disease,
congenital heart disease, and cardiac channelopathies
[24–28]. In our study, 25 of 70 (35.7%) patients had fQRS
without increased troponin levels. This can be explained
because fQRS can be seen without myocarditis and can be
an early significant ECG marker during the course of the
disease.
Despite the illness and some ECG changes, none
of the patients in our study had either arrhythmia or
pathologic ST-T changes. In a study by Samuel et al.
[29], 17% of patients had significant arrhythmias; some
of the arrhythmias resolved spontaneously, whereas
others needed antiarrhythmic therapy. Wang et al. found
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arrhythmias at a rate of 16.7% in a group of adult patients
[17].
Ho et al. reviewed a total of 31 studies on 51 patients
were included; 12 cases were confirmed myocarditis while
39 had possible myocarditis. In this group two patients had
normal ECG, while 7 cases had ECG features consistent
with myocarditis. Two patients had ventricular tachycardia,
one had nonspecific intraventricular conduction delay and
multiple premature ventricular complexes and one had
a low atrial ectopic rhythm. Three patients showed STsegment changes including elevation and depression, two
had T wave inversions, one had diffuse U waves and one
had low-voltage QRS complexes in limb leads [30].
In our study, PR, QRS, QTc, QTd, Tp-Te, Tp-Te/QT, TpTe/QTc parameters were all significant compared with the
control group. Despite of increased levels compared with
the control group by means of QRS duration and QTc, they
were still in the acceptable ranges. This can be explained
as we immediately diagnosed and evaluate these children,
therefore these can be accepted as the early results of ECG
parameters. On the other hand, none of the patients had
pathologic QTc prolongation during the illness or during
its treatment.
Thirty-six patients had PR prolongation, which can
be a marker of myocarditis or subclinical myocarditis.
Among these, only 25 had increased troponin levels.
Increased ventricular repolarization dispersion (QTd) is
associated with malignant arrhythmias and has prognostic
importance in terms of mortality and sudden cardiac death
[31]. However, it has lost its significance in repolarization,
thus researchers have begun to search for another ECG
parameter for ventricular repolarization [33,34]. During the
last decades, the Tpeak-Tend interval has been intensively
investigated as an ECG marker of arrhythmic and mortality
outcomes in various disorders, including chronic and acute
forms of ischemic heart disease. Tpeak-Tend demonstrated
an association with malignant arrhythmias in such cases
[34].
Tp-Te interval and Tp-Te/QT ratio have been
evaluated as actual markers of increased dispersion of
ventricular repolarization [35,36]. Prolongation of Tp-Te
interval was related with increased mortality in Brugada
syndrome, long QT syndrome, and in patients with acute
myocardial infarction [36]. Tp-Te can be affected by body
weight and heart rate, so it has some limitations for use
as a repolarization marker. On the other hand, Tp-Te/
QT and Tp-Te/QTc are not affected by heart rate or body
weight. As a result, Tp-Te, Tp-Te/QT and Tp-Te/QTc
are novel markers of ventricular repolarization. Recent
studies showed that increased levels might be a marker
of ventricular arrhythmias. Yayla et al. found increased
levels of Tp-Te/QTc in a group of patients who underwent
radiofrequency catheter ablation, those whose ejection

fraction was less than 50% [37]. In our study, we observed
significantly increased levels of Tp-Te, Tp-Te/QT, and TpTe/QTc compared with the control group.
Gupta et al. claimed that the Tp-Te/QT ratio could be
used as an index of arrhythmogenesis, even in the presence
of short, normal or long QT intervals. Additionally, they
indicated that the Tp-Te/QT ratio was a better marker
of ventricular repolarization [36]. Ucar et al. found a
prolongation in the Tp-Te interval, and an increase in the
Tp-Te/QT and Tp-Te/QTc ratios in patients with acute
myocarditis when compared with healthy subjects [38] In
the present study, none of the patients had any arrhythmias
such as ventricular premature contractions and ventricular
tachycardia. This may be explained as subclinical altered
properties of the myocardium causing electrophysiologic
abnormalities represented by the Tp-Te and Tp-Te/QTc
ratio, despite patients having a good clinical condition.
The best-known clinical condition in children regarding
COVID-19 is PIMS (PIMS/Kawa-COVID-19). Pouletty et
al. showed that severe disease and intensive care requirement
was observed in 44% of their cases [39]. Gonzales et al.
showed a relationship between COVID 19 and Kawasaki
disease like symtoms in the meta analysis [40]. Loomba et
al. also mentioned this relation in their review [41]. The
characteristics of this syndrome resemble those of Kawasaki
disease (KD), an inflammatory syndrome in children that
can lead to coronary artery abnormalities due to vasculitis.
Kawasaki disease may occasionally trigger macrophage
activation syndrome (MAS), a condition in which there is
uncontrolled activation and proliferation of macrophages
and other cell types, and could lead to multiorgan system
dysfunction. A relatively small number of children have
developed PIMS related to the COVID-19 pandemic. PIMS
has been characterized as the presentation of a child with
high, persistent fever with elevated inflammatory markers
such as neutrophilia, elevated C-reactive protein (CRP),
and evidence of single or multiorgan dysfunction.
In our group, during 3 months only 3 patients were
diagnosed as having PIMS; they were treated with singledose immunoglobulin (2 g/kg), and acetylsalicylic acid
(first antiinflammatory after the antiaggregant dose). The
patients had coronary artery dilatation (z score > 2.5), and
elevated inflammatory markers. Only one patient needed
intensive care unit treatment, because of the necessity of
inotropic support and resolved the symptoms in a few days,
as described in patient number two.
In this study, we also evaluated the systolic and diastolic
functions during the illness. On the TTE, 20 patients
had mild mitral insufficiency, among whom only 5 had
systolic dysfunction (ejection fraction < 55%). There was
no significant difference between the patient and control
groups, except for IVRT in terms of mean systolic and
diastolic function parameters. IVRT was significantly
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lower than in the control group. As we all know, IVRT is a
measure of time from the onset of the aortic valve closure
spike artifact to the onset of the mitral valve opening spike
artifact. The first cause of shortening may be the increased
left ventricle pressure, despite of mitral valve insufficiency
in this patient group. Another reason can be an occult
atrial fibrillation ECG pattern that can be result as an
elevated left atrial pressure. We think that, destruction and
inflammatory process in the cellular levels may cause this
and also diastolic dysfunction.
6. Conclusion
Despite all the adult studies, the effects of COVID‐19 on
myocardial function are not well established in children.
The thought that children are less affected by the illness
may be a misconception. We conclude that, physicians
should be careful with the course of the disease even if
the child is not very unwell, in terms of ECG parameters
such as Tp-Te, Tp-Te/QT, Tp-Te/QTc, which are early
markers of arrhythmia. Because of the consequences that

can cause arrhythmia such as decreased IVRT, increased
Tp-Te, Tp-Te/QT, and Tp-Te/QTc; acetyl salicylic acid can
be used as co-treatment during treatment. Based on what
has been discovered and hypothesized regarding cardiac
involvement in COVID‐19, there is a need for further
studies, especially in children.
7. Limitations
This study has several limitations. Firstly, we wanted to
correlate the ECG parameters after the infection, but no
patients wanted to come back to the hospital owing to
the ongoing pandemic situation. Many evaluations on
TTE could be performed, but these echocardiographic
assessments were conducted very quickly with the desire
to protect the echocardiographer from the virus.
8. Ethical standards
The study was approved by the local ethics committee
of University (Date: 24.07.2020-09.2020.717), and the
Turkish Ministry of Health (2020-06-08/T19-55-10).
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